Posttranslational cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia.
AUTOR(ES)
Shibasaki, Y
RESUMO
Familial hyperproinsulinemia is characterized by the accumulation of proinsulin-like material (PLM) in the plasma of affected patients. This disorder is inherited in an autosomal dominant fashion. The accumulation of PLM is thought to be due to the impaired conversion of proinsulin to insulin. Although PLM has been suggested to have an amino acid substitution, it has been impossible to locate and identify a substituted amino acid, due to the difficulty in isolating sufficient amounts of PLM from plasma samples. Therefore, we analyzed leukocyte DNA from one member of a proinsulinemic family, and we found a point mutation that changed guanine to adenine in the insulin gene. This transition implies that a substitution of histidine for arginine has occurred at amino acid position 65. Furthermore, it indicates that arginine at 65 is essential for the conversion of proinsulin to insulin. Our results suggest a novel mechanism by which disease can be incurred: a heritable disorder can result from a posttranslational processing abnormality caused by a point mutation.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=423787Documentos Relacionados
- Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion.
- A mutation in the B chain coding region is associated with impaired proinsulin conversion in a family with hyperproinsulinemia.
- A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto).
- Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material.
- Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site.